Literature DB >> 10671383

Late-onset schizophrenia and very-late-onset schizophrenia-like psychosis: an international consensus. The International Late-Onset Schizophrenia Group.

R Howard1, P V Rabins, M V Seeman, D V Jeste.   

Abstract

OBJECTIVE: Although schizophrenia is generally regarded as an illness with onset in late adolescence or early adult life, a sizeable minority of patients first become ill in middle or old age. Inconsistencies in diagnostic systems and nomenclature, coupled with a tendency among most schizophrenia researchers to ascribe late-onset psychoses to organic factors, have led to such cases occupying an ambiguous position in relation to schizophrenia. Through systematic review of the literature and publication of a consensus statement from an international group of experts in the field, this article aims to clarify the positions of late-onset schizophrenia and very-late-onset schizophrenia-like psychosis.
METHOD: The authors conducted a MEDLINE literature review and developed a consensus statement summarizing the findings from 2 days of debate and discussion by members of the International Late-Onset Schizophrenia Group.
RESULTS: The group achieved consensus on diagnosis, nomenclature, treatment guidelines, and future research directions.
CONCLUSIONS: In terms of epidemiology, symptom profile, and identified pathophysiologies, the diagnoses of late-onset schizophrenia (illness onset after 40 years of age) and very-late-onset schizophrenia-like psychosis (onset after 60 years) have face validity and clinical utility. General adoption of these categories will foster systematic investigation of such patients.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10671383     DOI: 10.1176/appi.ajp.157.2.172

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  74 in total

Review 1.  Care of older people: Mental health problems.

Authors:  A Burns; T Dening; R Baldwin
Journal:  BMJ       Date:  2001-03-31

Review 2.  Antipsychotic treatment for late-life schizophrenia.

Authors:  Jeremy A Sable; Dilip V Jeste
Journal:  Curr Psychiatry Rep       Date:  2002-08       Impact factor: 5.285

3.  Psychiatric conditions that can mimic early behavioral variant frontotemporal dementia: the importance of the new diagnostic criteria.

Authors:  Facundo Manes
Journal:  Curr Psychiatry Rep       Date:  2012-10       Impact factor: 5.285

4.  Treatment of subsyndromal depressive symptoms in middle-age and older patients with schizophrenia: effect of age on response.

Authors:  John Kasckow; Ian Fellows; Shahrokh Golshan; Ellen Solorzano; Thomas Meeks; Sidney Zisook
Journal:  Am J Geriatr Psychiatry       Date:  2010-09       Impact factor: 4.105

Review 5.  Elderly patients with schizophrenia and depression: diagnosis and treatment.

Authors:  Kandi Felmet; Sidney Zisook; John W Kasckow
Journal:  Clin Schizophr Relat Psychoses       Date:  2011-01

Review 6.  DSM-5 and Mental Disorders in Older Individuals: An Overview.

Authors:  Perminder S Sachdev; Adith Mohan; Lauren Taylor; Dilip V Jeste
Journal:  Harv Rev Psychiatry       Date:  2015 Sep-Oct       Impact factor: 3.732

7.  Elevated C-reactive protein associated with late- and very-late-onset schizophrenia in the general population: a prospective study.

Authors:  Marie Kim Wium-Andersen; David Dynnes Ørsted; Børge Grønne Nordestgaard
Journal:  Schizophr Bull       Date:  2013-08-31       Impact factor: 9.306

Review 8.  Antipsychotic medication for elderly people with schizophrenia.

Authors:  R G Marriott; W Neil; S Waddingham
Journal:  Cochrane Database Syst Rev       Date:  2006-01-25

Review 9.  Brain stimulation in the treatment of late-life severe mental illness other than unipolar nonpsychotic depression.

Authors:  Angela Y Liu; Tarek K Rajji; Daniel M Blumberger; Zafiris J Daskalakis; Benoit H Mulsant
Journal:  Am J Geriatr Psychiatry       Date:  2013-07-23       Impact factor: 4.105

10.  Medication adherence among older adults with schizophrenia.

Authors:  Heather C Leutwyler; Patrick J Fox; Margaret Wallhagen
Journal:  J Gerontol Nurs       Date:  2013-01-18       Impact factor: 1.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.